Mycobacterium leprae-induced demyelination: A model for early nerve degeneration

Current Opinion in Immunology

Volumn 16, Issue 4, 2004, Pages 511-518

  Rambukkana, Anura ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

central nervous system; CNS; DRP2; dystroglycan related protein 2; G; GBS; globular; Guillain Barre syndrome; LCMV; lepromatous leprosy; LL; lymphocytic choriomeningitis virus; MS; multiple sclerosis; peripheral nervous system; PGL 1; phenolic glycolipid 1; PNS

Indexed keywords

CELL RECEPTOR; DYSTROGLYCAN; MEROSIN; SCHWANN CELL RECEPTOR; UNCLASSIFIED DRUG;

AXONAL INJURY; BACTERIUM IDENTIFICATION; DEGENERATIVE DISEASE; DEMYELINATION; HUMAN; IMMUNE RESPONSE; LEPROSY; MOLECULAR BIOLOGY; MYCOBACTERIUM LEPRAE; MYELINATION; NERVE DEGENERATION; NONHUMAN; ONSET AGE; REVIEW;

ANIMALS; AXONS; DEMYELINATING AUTOIMMUNE DISEASES, CNS; DYSTROGLYCANS; DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX; HUMANS; LEPROSY; MICE; MYCOBACTERIUM LEPRAE; MYELIN SHEATH; SCHWANN CELLS;

EID: 3042814735     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2004.05.021     Document Type: Review

References (46)

1. Smith K.J., Blakemore W.F., Murray J.A., Patterson R.C. Internodel myelin volume and axon surface area. A relationship determining myelin thickness? J Neurol Sci. 55:1982;231-246
2. Waxman SG: Pathophysiology of demyelinated and remyelinated axons. In: Cook SD. Ed. Handbook of multiple sclerosis. 2nd ed. New York: Marcel Dekker, 1996: 257-294.
3. Webster H.D., Martin J.R., O'Connell M.F. The relationship between interphase Schwann cells and axons before myelination: a quantitative electron microscopic study. Dev Biol. 32:1973;401-416
4. Salzer J.L. Polarized domains of myelinated axons. Neuron. 40:2003;297-318
5. Poliak S., Peles E. The local differentiation of myelinated axons at nodes of Ranvier. Nat Rev Neurosci. 4:2003;968-980
6. Scherer S.S., Arroyo E.J. Recent progress on the molecular organization of myelinated axons. J Peripher Nerv Syst. 7:2002;1-12
7. Johnson PC: Peripheral nerve pathology. In text book of Neuropathology, 3rd Ed. R.L. Davis, and D.M. Robertson, eds. (Baltimore, MD, William and Wilkins) 1997. p. 1233-1323.
8. Job C.K. Nerve damage in leprosy. Int J Lepr Other Mycobact Dis. 57:1989;532-539
9. Waxman S.G. Demyelinating diseases-new pathological insights, new therapeutic targets. N Engl J Med. 338:1998;323-325
10. Bjartmar C., Trapp B.D. Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr Opin Neurol. 14:2001;271-278
11. Hiraga A., Mori M., Ogawara K., Hattori T., Kuwabara S. Differences in patterns of progression in demyelinating and axonal Guillain-Barre syndromes. Neurology. 61:2003;471-474
12. Rambukkana A., Zanazzi G., Tapinos N., Salzer J.L. Contact dependent demyelination by Mycobacterium leprae in the absence of immune responses. Science. 296:2002;927-931
13. Ng V., Zanazzi G., Timpl R., Talts J.F., Salzer J.L., Brennan P.J., Rambukkana A. Role of the cell wall phenolic glycolipid-1 in the peripheral nerve predilection of Mycobacterium leprae. Cell. 103:2000;511-524
14. Shimoji Y., Ng V., Matsumura K., Fischetti V.A., Rambukkana A. A 21-kDa surface protein of Mycobacterium leprae binds peripheral nerve laminin-2 and mediates Schwann cell invasion. Proc Natl Acad Sci USA. 96:1999;9857-9862
15. Rambukkana A., Salzer J.L., Yurchenco P.D., Tuomanen E.I. Neural targeting of Mycobacterium leprae mediated by the G domain of the laminin-alpha2 chain. Cell. 88:1997;811-821
16. Rambukkana A., Yamada H., Zanazzi G., Mathus T., Salzer J.L., Yurchenco P.D., Campbell K.P., Fischetti V.A. Role of alpha-dystroglycan as a Schwann cell receptor for Mycobacterium leprae. Science. 282:1998;2076-2079
17. Talts J.F., Andac Z., Gohring W., Brancaccio A., Timpl R. Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan, and several extracellular matrix proteins. EMBO J. 18:1999;863-870
18. Bunge M.B., Bunge R.P. Linkage between Schwann cell extracellular matrix production and ensheathment function. Ann N Y Acad Sci. 486:1996;241-247
19. Patton B.L., Miner J.H., Chiu A.Y., Sanes J.R. Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice. J Cell Biol. 139:1997;1507-1521
20. Uziyel Y., Hall S., Cohen J. Influence of laminin-2 on Schwann cell-axon interactions. Glia. 32:2000;109-121
21. Matsumura K., Yamada H., Saito F., Sunada Y., Shimizu T. Peripheral nerve involvement in merosin-deficient congenital muscular dystrophy and dy mouse. Neuromuscul Disord. 7:1997;7-12
22. Previtali S.C., Nodari A., Taveggia C., Pardini C., Dina G., Villa A., Wrabetz L., Quattrini A., Feltri M.L. Expression of laminin receptors in schwann cell differentiation: evidence for distinct roles. J Neurosci. 23:2003;5520-5530
23. Yamada H., Denzer A., Hori J., Tanaka H., Fujita S., Fukutaohi H., Shimizu T., Ruegg M.A., Matsumura K. Dystroglycan is a dual receptor for agrin and laminin-2 in Schwann cell membrane. J Biol Chem. 271:1996;23418-23423
24. Feltri M.L., Graus Porta D., Previtali S.C., Nodari A., Migliavacca B., Cassetti A., Littlewood-Evans A., Reichardt L.F., Messing A., Quattrini A., et al. Conditional disruption of beta1 integrin in Schwann cells impedes interactions with axons. J Cell Biol. 156:2002;199-209
25. Henry M.D., Campbell K.P. Dystroglycan inside and out. Curr Opin Cell Biol. 11:1999;602-607
26. Rambukkana A., Kunz S., Min J., Campbell K.P., Oldstone M.B. Targeting Schwann cells by nonlytic arenaviral infection selectively inhibits myelination. Proc Natl Acad Sci USA. 100:2003;16071-16076 Selective targeting of α-dystroglycan on Schwann cells by LCMV and Lassa fever virus from the non-lytic Arenavirus family was demonstrated. Persistent LCMV infection rendered immature Schwann cells incapable of forming mature myelin sheath during differentiation, and caused demyelination in mature Schwann cells that form myelin sheaths. A correlation between the disorganization of the laminin-2 network and downregulation of α-dystroglycan with myelin defects was demonstrated. Viral manipulation of dystroglycan and laminin-associated functions in Schwann cells was proposed for myelination and demyelination. The study also shows the use of LCMV as a tool to dissect the molecular basis of myelination.
27. Cao W., Henry M.D., Borrow P., Yamada H., Elder J.H., Ravkov E.V., Nichol S.T., Compans R.W., Campbell K.P., Oldstone M.B. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science. 282:1998;2079-2081
28. Masaki T., Matsumura K., Hirata A., Yamada H., Hase A., Arai K., Shimizu T., Yorifuji H., Motoyoshi K., Kamakura K. Expression of dystroglycan and the laminin-alpha 2 chain in the rat peripheral nerve during development. Exp Neurol. 174:2002;109-117
29. Masaki T., Matsumura K., Saito F., Sunada Y., Shimizu T., Yorifuji H., Motoyoshi K., Kamakura K. Expression of dystroglycan and laminin-2 in peripheral nerve under axonal degeneration and regeneration. Acta Neuropathol (Berl). 99:2000;289-295
30. Hunter S.W., Brennan P.J. A novel phenolic glycolipid from Mycobacterium leprae possibly involved in immunogenicity and pathogenicity. J Bacteriol. 147:1981;728-735
31. Saito F., Moore S.A., Barresi R., Henry M.D., Messing A., Ross-Barta S.E., Cohn R.D., Williamson R.A., Sluka K.A., Sherman D.L., et al. Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron. 38:2003;747-758 A critical role for dystroglycan in myelination and peripheral nerve functions was demonstrated by selective deletion of Schwann cell dystroglycan. Slowed nerve conduction and nodal changes, including reduced sodium channel density and disorganized microvilli, were observed in mutant mice. Data suggest that dystroglycan is crucial for both myelination and normal maintenance of voltage-gated sodium channels at nodes of Ranvier, possibly by mediating trans interactions between Schwann cell microvilli and the nodal axolemma.
32. Sherman D.L., Fabrizi C., Gillespie C.S., Brophy P.J. Specific disruption of a schwann cell dystrophin-related protein complex in a demyelinating neuropathy. Neuron. 30:2001;677-687
33. Gillespie C.S., Sherman D.L., Fleetwood-Walker S.M., Cottrell D.F., Tait S., Garry E.M., Wallace V.C., Ure J., Griffiths I.R., Smith A., Brophy P.J. Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice. Neuron. 26:2000;523-531
34. Parkinson D.B., Dickinson S., Bhaskaran A., Kinsella M.T., Brophy P.J., Sherman D.L., Sharghi-Namini S., Duran Alonso M.B., Mirsky R., Jessen K.R. Regulation of the myelin gene periaxin provides evidence for Krox-20-independent my elin-related signalling in Schwann cells. Mol Cell Neurosci. 23:2003;13-27
35. Scherer S.S. Myelination: some receptors required. J Cell Biol. 156:2002;13-15
36. Wrabetz L., Feltri M.L. Do Schwann cells stop, DR(o)P2, and roll? Neuron. 30:2001;642-644
37. Rambukkana A. Molecular basis for the peripheral nerve predilection of Mycobacterium leprae. Curr Opin Microbiol. 4:2001;21-27
38. Mukherjee R., Antia N.H. Host-parasite interrelationship between M. leprae and Schwann cells in vitro. Int J Lepr Other Mycobact Dis. 54:1986;632-638
39. Shetty V.P., Antia N.H. Light and ultrastructural study of sciatic nerve lesions induced using intraneural injection of viable Mycobacterium leprae in normal and immunosuppressed Swiss white mice. Int J Lepr Other Mycobact Dis. 70:2002;25-33
40. Shetty V.P., Jacobs J.M., Anita N.H. The pathology of early leprous neuropathy. J Neurol Sci. 88:1988;115-135
41. Scherer SS, Salzer JL: In: Glial cell development, Jessen KR, Richardson WD, eds. (Bios Scientific Publishers, Ltd., London, UK 1996; pp. 165-196.
42. Pasare C., Medzhitov R. Toll-like receptors: balancing host resistance with immune tolerance. Curr Opin Immunol. 15:2003;677-682
43. Krutzik S.R., Ochoa M.T., Sieling P.A., Uematsu S., Ng Y.W., Legaspi A., Liu P.T., Cole S.T., Godowski P.J., Maeda Y., et al. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat Med. 9:2003;525-532 This study provides evidence that the outcome of the immune response in leprosy is determined in part by the influence of the local cytokine environment on the regulated expression and activation of TLR1 and TLR2. The activation of TLRs at the site of disease was proposed to contribute to host defense against microbial pathogens.
44. Oliveira R.B., Ochoa M.T., Sieling P.A., Rea T.H., Rambukkana A., Sarno E.N., Modlin R.L. Expression of Toll-like receptor 2 on human Schwann cells: a mechanism of nerve damage in leprosy. Infect Immun. 71:2003;1427-1433
45. Artung H.P. Immune-mediated demyelination. Ann Neurol. 33:1993;563-567
46. Spierings E., de Boer T., Wieles B., Adams L.B., Marani E., Ottenhoff T.H. Mycobacterium leprae-specific, HLA class II-restricted killing of human Schwann cells by CD4+ Th1 cells: a novel immunopathogenic mechanism of nerve damage in leprosy. J Immunol. 166:2001;5883-5888